Mannheim/Heidelberg, 03.05.2022. Until now, the potential for innovation and entrepreneurship of many students, researchers and other employees in the field of medical technology remained largely untapped due to massive hurdles. With the “Go-To-Market Academy” seminar series, Innovation in Health, in collaboration with the EIT Health Regional Innovation Hub (RIH) Germany-Switzerland, aims to change this step […]
EIT Health RIH Germany-Switzerland has selected 12 start-ups to continue their EIT Health Catapult journey and compete in the Regional Selection, where an expert jury will select 2 best-of-the-best business concepts from each category: MedTech, Biotech and Digital Health. EIT Health Catapult is a training and competition programme that boosts the development of top-notch European […]
Our new Think Tank report is out now, gathering expert insights into the potential for innovation in health to support the creation of more resilient and sustainable healthcare systems. Innovation can enhance health systems by improving disease prevention, enabling personalised medicine and increasing access to care. The COVID-19 crisis was an eye-opener globally on the […]
Tubulis GmbH closed €60 Million Series B financing to accelerate its ADC pipeline and expand its breadth of platform technologies. Tubulis generates uniquely matched antibody-drug conjugates (ADCs) by combining proprietary novel technologies with disease-specific biology. In more general terms, this means that they use the targeting mechanism of an antibody, that is specific to a […]
With our offices in Mannheim and Heidelberg we are the regional service point of EIT Health RIH Germany-Switzerland. We are here to help with all questions about the offerings and services of EIT Health.